Understand the source comparison
Best Research Peptides for Achilles Tendonitis: Peptide Comparison
BPC-157 Growth hormone receptor upregulation, VEGF pathway activation 0–72 hours post-injury (acute phase) 28–30 days at 2–8°C 55–62% faster tendon-to-bone healing (University of Zagreb, 2023) Best suited for acute injury models where vascular access determine
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- Growth hormone receptor upregulation, VEGF pathway activation
- 0–72 hours post-injury (acute phase)
- 28–30 days at 2–8°C
- 55–62% faster tendon-to-bone healing (University of Zagreb, 2023)
- Best suited for acute injury models where vascular access determines outcome. Requires precise timing
- TB-500
- Actin-binding anti-inflammatory, endothelial progenitor cell activation
- 4–14 days post-injury (proliferative phase)
- 60 days at 2–8°C
- 40% reduction in scar tissue formation (Wound Repair and Regeneration)
- Superior for protocols focused on tissue quality rather than healing speed. Longer stability window
- GHK-Cu
- Copper-dependent collagen synthesis and remodeling modulation
- All phases (0–90 days). Continuous administration
- 14 days at 2–8°C
- 30–35% improved tensile strength (UC study)
- Only peptide effective across entire healing timeline but requires most frequent reconstitution